CDK2 translational down-regulation during endothelial senescence
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 307 (1) , 118-130
- https://doi.org/10.1016/j.yexcr.2005.03.025
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (F32CA86437, W81XWH-04-1-0316)
- U.S. Department of Defense
- Medical Research and Materiel Command
This publication has 74 references indexed in Scilit:
- Senescence and its bypass in the vascular endotheliumFrontiers in Bioscience-Landmark, 2005
- The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 PromoterPublished by Elsevier ,2003
- Telomerase and Telomeres: From Basic Biology to Cancer TreatmentCancer Investigation, 2002
- Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cellsOncogene, 2001
- Complex Mechanisms Underlying Impaired Activation of Cdk4 and Cdk2 in Replicative Senescence: Roles of p16, p21, and Cyclin D1Experimental Cell Research, 1999
- Extension of Life-Span by Introduction of Telomerase into Normal Human CellsScience, 1998
- Cyclin/Cdk-Dependent Initiation of DNA Replication in a Human Cell-Free SystemPublished by Elsevier ,1997
- Telomeres shorten during ageing of human fibroblastsNature, 1990
- A theory of marginotomyJournal of Theoretical Biology, 1973
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971